View on AAMS · All conferences
We present a novel pipeline leveraging AlphaFold protein structure predictions to identify potential drug targets for atherosclerosis and heart failure. Using computational screening of 12,000 protein-ligand interactions, we identified 23 promising lead compounds with significant anti-inflammatory properties.
Keywords: AlphaFold, drug discovery, protein folding, cardiovascular